skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Role of grape seed polyphenols in Alzheimer’s disease neuropathology

Review

(2048) Views  (1401) Full article downloads

Authors: Giulio Maria Pasinetti, Lap Ho

Published Date August 2010 Volume 2010:2 Pages 97 - 103
DOI: http://dx.doi.org/10.2147/NDS.S6898

Giulio Maria Pasinetti1,2, Lap Ho1

1Department of Neurology, Mount Sinai School of Medicine, New York; 2Geriatric Research, Education and Clinical Center, James J Peters Veteran Affairs Medical Center, Bronx, New York, USA

Abstract: Alzheimer’s disease (AD) is an age-related neurodegenerative condition ­characterized by a progressive decline in cognitive function. AD affects approximately five million people in the US, creating a devastating financial burden on health care costs and an emotional ­burden on caregivers. To date, there is no cure for AD, so researchers are continually exploring novel ­avenues for the prevention and treatment of this condition. In this article, we present some ­findings from our laboratory and those of others on the potential benefits of a grape seed ­polyphenolic extract (GSPE) for the prevention and treatment of AD, including its c­hemical composition, bioactivity, bioavailability, safety, and tolerability, and the mechanisms by which it interferes with AD pathogenesis. Findings presented in this review article support the ­development of GSPE as a preventative and/or therapeutic agent in AD.

Keywords: alzheimer’s disease, neurodegeneration, polyphenols






Readers of this article also read:

Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Potential renovascular hypertension, space missions, and the role of magnesium
Polyphenols as dietary supplements: A double-edged sword
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Everolimus-eluting stents: update on current clinical studies
Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University